NUZ 0.00% 23.0¢ neurizon therapeutics limited

Of course it's a possibility the trial fail and PAA is...

  1. 1,424 Posts.
    lightbulb Created with Sketch. 291
    Of course it's a possibility the trial fail and PAA is worthless.Is it also possible MPL is the best treatment for MND and will be a blockbuster pharmaceutical asset worth north of $2B? MC $80M. Do you like the odds?
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.